A detailed history of Woodline Partners LP transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Woodline Partners LP holds 298,569 shares of AXSM stock, worth $26 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares
298,569
Previous 318,011 6.11%
Holding current value
$26 Million
Previous $25.6 Million 4.79%
% of portfolio
0.24%
Previous 0.26%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$78.93 - $95.84 $1.53 Million - $1.86 Million
-19,442 Reduced 6.11%
298,569 $26.8 Million
Q2 2024

Aug 14, 2024

SELL
$65.72 - $80.5 $2.77 Million - $3.39 Million
-42,117 Reduced 11.7%
318,011 $25.6 Million
Q1 2024

May 15, 2024

SELL
$69.39 - $97.64 $14 Million - $19.7 Million
-202,035 Reduced 35.94%
360,128 $28.7 Million
Q4 2023

Feb 14, 2024

BUY
$57.42 - $83.61 $6.32 Million - $9.2 Million
110,056 Added 24.34%
562,163 $44.7 Million
Q3 2023

Nov 14, 2023

BUY
$69.25 - $82.21 $843,603 - $1 Million
12,182 Added 2.77%
452,107 $31.6 Million
Q2 2023

Aug 14, 2023

SELL
$58.41 - $90.35 $7.65 Million - $11.8 Million
-130,900 Reduced 22.93%
439,925 $31.6 Million
Q1 2023

May 15, 2023

BUY
$58.39 - $75.0 $20.3 Million - $26 Million
347,173 Added 155.23%
570,825 $35.2 Million
Q4 2022

Feb 14, 2023

BUY
$39.94 - $79.72 $8.93 Million - $17.8 Million
223,652 New
223,652 $17.3 Million

Others Institutions Holding AXSM

About Axsome Therapeutics, Inc.


  • Ticker AXSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,878,000
  • Market Cap $3.73B
  • Description
  • Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...
More about AXSM
Track This Portfolio

Track Woodline Partners LP Portfolio

Follow Woodline Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Woodline Partners LP with notifications on news.